Wegovy Medicare Coverage: How to Get Wegovy Covered

Wondering if Medicare covers Wegovy? Talk to a DevotedDOc physician today.

Wondering whether Wegovy Medicare coverage is available? The answer is yes—but only for beneficiaries who meet specific eligibility requirements. Beginning July 1, 2026, Medicare introduced the Medicare GLP-1 Bridge Program to expand access to certain FDA-approved GLP-1 medications for chronic weight management, including Wegovy, at a fixed monthly cost for qualifying patients.

Not everyone with Medicare automatically qualifies. Coverage depends on your Medicare prescription drug plan, body mass index (BMI), medical history, and whether you’re using Wegovy specifically for weight management. Your healthcare provider must also determine that the medication is appropriate for you and submit a prior authorization before Medicare approves coverage.

If you’re exploring medical weight loss solutions, understanding how the Medicare GLP-1 Bridge Program works can help you determine whether Wegovy may be an option. This guide explains who qualifies, how to get Wegovy covered, what Medicare Part D requirements apply, and what steps you’ll need to complete before starting treatment.

Learn more about DevotedDOc’s weight loss solutions if you’re considering medical weight management.

For the official Medicare eligibility criteria and coverage details, visit the Medicare GLP-1 Bridge Program page.

Does Medicare Cover Wegovy?

Yes. Starting July 1, 2026, eligible Medicare beneficiaries may receive Wegovy through the Medicare GLP-1 Bridge Program, a nationwide demonstration program designed to improve access to certain GLP-1 medications prescribed for chronic weight management.

Unlike traditional Medicare Part D prescription coverage, the Medicare GLP-1 Bridge Program operates separately and provides eligible patients with a one-month supply of covered medications for a $50 monthly copayment. Current covered medications include Wegovy (both injection and tablet formulations), Foundayo®, and the Zepbound® KwikPen®.

However, eligibility is not automatic. Beneficiaries must meet specific Medicare Part D, BMI, and medical criteria before coverage can be approved.

When will Medicare cover Wegovy?

The Medicare GLP-1 Bridge Program officially began on July 1, 2026. Eligible beneficiaries who meet the program’s clinical requirements and receive prior authorization from Medicare can begin receiving covered GLP-1 medications through participating pharmacies once approval is complete.

Who Qualifies for Wegovy Through Medicare?

Although Medicare now provides a pathway for eligible beneficiaries to receive Wegovy, not everyone with Medicare qualifies. Eligibility depends on your prescription drug coverage, age, body mass index (BMI), qualifying medical conditions, and whether you already receive coverage for a GLP-1 medication through your existing Medicare Part D plan.

You must have eligible Medicare Part D coverage

To qualify for the Medicare GLP-1 Bridge Program, you must have Medicare prescription drug coverage (Part D). Eligible plans include:

• A standalone Medicare Prescription Drug Plan (PDP)
• A Medicare Advantage plan with prescription drug coverage (MA-PD)
• A Special Needs Plan (SNP)
• An Employer or Union Group Waiver Plan (EGWP)
• The Limited Income Newly Eligible Transition (LI NET) program

Without eligible Medicare Part D coverage, you cannot participate in the Medicare GLP-1 Bridge Program.

You must meet Medicare’s BMI requirements

In addition to having eligible prescription drug coverage, Medicare requires beneficiaries to meet one of three BMI eligibility pathways when beginning Wegovy treatment.

You may qualify if your BMI is 35 or higher, regardless of other qualifying conditions.

If your BMI is between 30 and 34.99, you must also have at least one qualifying medical condition, including:

• Prediabetes
• Uncontrolled high blood pressure (hypertension)
• Chronic kidney disease (stage 3a or higher)
• Heart failure with preserved ejection fraction (diastolic heart failure)
• A previous heart attack or stroke
• Symptomatic peripheral artery disease

If your BMI is between 27 and 29.99, you may qualify if you have one of the following:

• Prediabetes
• A previous heart attack or stroke
• Symptomatic peripheral artery disease

Your healthcare provider will review your BMI, medical history, and current health conditions to determine whether you meet Medicare’s eligibility requirements before submitting your prior authorization.

Who is not eligible?

Some Medicare beneficiaries are not eligible for the Medicare GLP-1 Bridge Program, even if they are interested in taking Wegovy for weight loss.

You are generally not eligible if you:

• Already receive Wegovy or another eligible GLP-1 medication through your existing Medicare Part D prescription coverage.
• Are taking a GLP-1 medication for type 2 diabetes, as coverage may instead be available through your regular Medicare Part D plan.
• Have moderate-to-severe obstructive sleep apnea or fatty liver disease (MASH), since these conditions may also qualify for coverage outside of the Bridge Program through your Part D benefits.

If you’re unsure which Medicare pathway applies to your situation, reviewing the requirements with a healthcare provider is the best way to determine whether you may qualify for coverage.

How to Get Wegovy Covered by Medicare

If you meet the Medicare GLP-1 Bridge Program eligibility requirements, getting Wegovy covered involves more than simply filling a prescription. Your healthcare provider must confirm that the medication is medically appropriate, complete the required documentation, and obtain approval before your pharmacy can dispense the medication.

Step 1: Schedule an evaluation with a healthcare provider

The first step is to meet with a healthcare provider who can determine whether Wegovy is appropriate for your weight management goals. During your evaluation, your provider will review your BMI, medical history, current medications, and any qualifying health conditions to determine whether you meet Medicare’s requirements.

Step 2: Receive a prescription for Wegovy

If your healthcare provider determines that Wegovy is appropriate, they will send a prescription to your preferred pharmacy. However, the prescription alone does not guarantee coverage under the Medicare GLP-1 Bridge Program.

Before Medicare will approve the medication, additional documentation is often required.

Step 3: Complete the prior authorization process

Most beneficiaries must have a prior authorization submitted by their healthcare provider before Medicare approves Wegovy coverage.

As part of the prior authorization, your provider must certify that:

• You meet the program’s eligibility requirements.
• Wegovy is being prescribed for chronic weight management.
• You are participating in a lifestyle program that includes healthy eating and regular physical activity.

Once submitted, Medicare reviews the request before making a coverage determination.

Step 4: Wait for Medicare’s approval

After Medicare reviews your prior authorization, you will receive notification of the decision. If your request is approved, Medicare will send you a letter confirming your coverage under the Medicare GLP-1 Bridge Program.

For most beneficiaries, approved prior authorizations remain valid through December 31, 2027, including refills and dose adjustments, unless you switch to a different GLP-1 medication.

If you’d like to learn more about how the program works, including eligibility requirements and coverage details, read our guide to the Medicare GLP-1 Bridge Program.

Step 5: Pick up your prescription

Once your approval is complete, your pharmacy can dispense your Wegovy prescription. Eligible beneficiaries pay a $50 copayment for each one-month supply, regardless of whether the medication contains 28 or 30 days of treatment.

Depending on the pharmacy, you may be asked to provide your Medicare number or the last four digits of your Social Security number to help process the prescription under the Bridge Program.

How Much Does Wegovy Cost With Medicare?

One of the biggest advantages of the Medicare GLP-1 Bridge Program is its predictable pricing. Eligible beneficiaries pay a $50 copayment for a one-month supply of covered GLP-1 medications, including Wegovy. This fixed cost helps make treatment more affordable for people who qualify through the program.

However, it’s important to understand that this temporary Medicare program operates separately from your regular Medicare Part D prescription drug benefit. As a result, some of the usual Part D cost-sharing rules do not apply.

What does the $50 monthly copayment include?

If your Wegovy prescription is approved through the Medicare GLP-1 Bridge Program, you’ll pay $50 for each 28- or 30-day supply, depending on the medication and packaging.

The copayment remains the same regardless of the prescribed maintenance dose, provided your treatment continues under an approved prior authorization.

What the copayment does not cover

Because Wegovy is covered through the Medicare GLP-1 Bridge Program rather than your standard Part D benefit, the monthly copayment:

• Does not count toward your Medicare Part D deductible.
• Does not count toward your annual Part D out-of-pocket maximum.
• Does not appear on your Medicare Part D Explanation of Benefits (EOB).
• Does not appear on your Medicare Summary Notice (MSN).
• Cannot be reduced through the Extra Help program.
• Cannot be spread across multiple months through the Medicare Prescription Payment Plan.

You may still have other healthcare costs associated with your treatment, such as office visits, laboratory testing, or follow-up appointments, depending on your individual Medicare coverage and healthcare provider.

Can You Get Wegovy Through Telehealth?

For many people, the answer is yes. Telehealth has made it easier to connect with licensed healthcare providers who can evaluate whether Wegovy is appropriate for weight management without requiring an in-person office visit.

During a telehealth appointment, your healthcare provider can review your medical history, calculate your BMI, discuss your weight-loss goals, and determine whether you meet the Medicare GLP-1 Bridge Program requirements. If Wegovy is appropriate, they can prescribe the medication and complete the prior authorization process required for Medicare coverage.

If you’re interested in learning more about virtual weight-loss care, read our guide on getting a GLP-1 prescription through telehealth.

Keep in mind that using telehealth does not automatically guarantee Medicare coverage. You must still meet all eligibility requirements established by the Medicare GLP-1 Bridge Program, and your prior authorization must be approved before your prescription can be filled.

Is Wegovy Right for You?

Wegovy can be an effective option for chronic weight management, but it is not the right choice for everyone. Before starting treatment, your healthcare provider will evaluate your overall health, medical history, current medications, and weight-loss goals to determine whether Wegovy is appropriate for you.

Wegovy contains semaglutide, a GLP-1 receptor agonist that works by helping regulate appetite and slowing stomach emptying. When combined with healthy eating and regular physical activity, it can support meaningful, long-term weight loss for eligible patients. According to the Cleveland Clinic, Wegovy is given as a once-weekly injection and is intended to be used alongside lifestyle changes rather than as a replacement for them.

Lifestyle changes remain an important part of treatment

Even with medication, healthy habits continue to play an essential role in successful weight management. Medicare also requires healthcare providers to certify that eligible beneficiaries are participating in a lifestyle program focused on nutrition and physical activity as part of the Medicare GLP-1 Bridge Program.

The American Heart Association recommends combining healthy eating with regular physical activity to improve long-term health and help maintain weight loss. Small, sustainable lifestyle changes often produce better long-term results than restrictive diets alone. Learn more about the benefits of healthy weight management.

Be aware of possible side effects

Like any prescription medication, Wegovy may cause side effects. The most common include:

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Stomach discomfort
• Decreased appetite

Most side effects are mild to moderate and often improve as your body adjusts to treatment. However, more serious side effects can occur, so it’s important to contact your healthcare provider if you experience severe abdominal pain, persistent vomiting, signs of dehydration, or other concerning symptoms.

Regular follow-up helps support long-term success

Weight management is an ongoing process, and regular follow-up appointments allow your healthcare provider to monitor your progress, adjust your dose if needed, manage side effects, and ensure that Wegovy continues to be safe and effective for you.

If you’re comparing available medications before making a decision, our guide to comparing GLP-1 medication options can help you better understand how Wegovy compares with other treatments commonly prescribed for weight management.

Frequently Asked Questions

Find Out If You Qualify for Wegovy Through Medicare with DevotedDOc

If you’re interested in Wegovy for weight management, understanding your Medicare eligibility is the first step. A healthcare provider can review your BMI, medical history, current coverage, and treatment goals to determine whether you may qualify for the Medicare GLP-1 Bridge Program.

Schedule a consultation with DevotedDOc today to find out whether Wegovy may be covered through Medicare and explore the weight-loss treatment options that are right for you.